Intracerebroventricular infusion of (+)-4-propyl-9-hydroxy-naphthoxacine in monkeys with MPTP-induced akinesia.
de Yébenes
J G
JG
Departmento de Investigacion, Centro Ramon y Cajal, Madrid, Spain.
Fahn
S
S
Goodman
R
R
Jamrosik
Z
Z
Pezzoli
G
G
Popalski
S
S
D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine / Q000494:pharmacology*; D000818:Animals; D001921:Brain / Q000187:drug effects*; D004298:Dopamine / Q000378:metabolism; D015259:Dopamine Agents; D007276:Injections, Intraventricular; D008252:Macaca fascicularis; D008297:Male; D009043:Motor Activity / Q000187:drug effects*; D010078:Oxazines / Q000493:pharmacokinetics / Q000494:pharmacology*; D010302:Parkinson Disease, Secondary / Q000139:chemically induced*; D051381:Rats; D011954:Receptors, Dopamine / Q000187:drug effects
D015259:Dopamine Agents; D010078:Oxazines; D011954:Receptors, Dopamine; C042631:naxagolide; D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; D004298:Dopamine